| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0071740a09d052bbc1dcc2a7e9fbf78a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate |
2021-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d7ce77905fc9c6cb86b4c090ebd27e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dbdce126cca8629f2dcb92ee0c03174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bbd7185da063658ca5690817d93f260
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc054c9a7e83065c693569740738235 |
| publicationDate |
2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021205012-A1 |
| titleOfInvention |
Aptamers for use in the treatment of coronaviridae infections |
| abstract |
The present invention relates to new aptamer molecules for use in therapy of infections caused by viruses from the Coronaviridae family, a method of preventing infection caused by viruses from the Coronaviridae family in vitro/ex vivo, a pharmaceutical composition and a kit comprising such aptamer molecules, and the use of aptamer molecules for preventing infection of somatic cells with a virus from the Coronaviridae family. The present invention also relates to affinity molecules binding to specific and newly identified epitopes of a key enzyme of Coronaviridae viruses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114807148-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114807148-B |
| priorityDate |
2020-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |